• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压、醛固酮分泌增加及低血浆肾素活性经地塞米松治疗后缓解。

Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.

作者信息

Sutherland D J, Ruse J L, Laidlaw J C

出版信息

Can Med Assoc J. 1966 Nov 26;95(22):1109-19.

PMID:4288576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1935810/
Abstract

A father and son are described with a condition characterized by benign hypertension, potassium deficiency, increased aldosterone secretion rate (ASR), raised plasma volume and suppressed plasma renin activity (PRA). There were intermittent elevations of urine 17-ketosteroids and 17-hydroxycorticoids (17-OHCS) but no increase in urine THS, normal circadian rhythm of plasma 17-OHCS, and normal urine 17-OHCS response to dexamethasone and intravenous ACTH. Plasma ACTH and corticosterone secretion were not elevated. Pregnanetriol excretion was normal but urine pregnanediol was increased. At operation on the father no adrenal tumour was found; the excised left adrenal weighed 7 g. and showed nodular cortical hyperplasia; juxtaglomerular cells showed only occasional granules. Following operation hypertension persisted and ASR was half the preoperative value. All abnormalities in father and son were relieved by dexamethasone (DM) 2 mg. daily. The condition recurred following cessation of DM but was relieved by a second course of treatment. No such response to DM was seen in a normal subject or in a patient with Conn's syndrome. For a number of reasons it is suggested that patients with hypertension, increased ASR and low PRA be given a trial of dexamethasone treatment before undergoing adrenal surgery.

摘要

本文描述了一对父子患有某种病症,其特征为良性高血压、低钾血症、醛固酮分泌率(ASR)升高、血浆容量增加以及血浆肾素活性(PRA)受抑制。尿17 - 酮类固醇和17 - 羟皮质类固醇(17 - OHCS)有间歇性升高,但尿促甲状腺激素无增加,血浆17 - OHCS昼夜节律正常,尿17 - OHCS对地塞米松和静脉注射促肾上腺皮质激素(ACTH)的反应正常。血浆促肾上腺皮质激素(ACTH)和皮质酮分泌未升高。孕三醇排泄正常,但尿孕二醇增加。对父亲进行手术时未发现肾上腺肿瘤;切除的左肾上腺重7克,显示结节性皮质增生;球旁细胞仅偶尔可见颗粒。术后高血压持续存在,ASR为术前值的一半。父子俩的所有异常情况均通过每日2毫克地塞米松(DM)得到缓解。停用DM后病情复发,但第二疗程治疗使其缓解。正常受试者或原发性醛固酮增多症患者对DM无此反应。基于多种原因,建议高血压、ASR升高且PRA降低的患者在接受肾上腺手术前先试用糖皮质激素治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/1935810/3fa2b947eda6/canmedaj01192-0010-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/1935810/3fa2b947eda6/canmedaj01192-0010-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/1935810/3fa2b947eda6/canmedaj01192-0010-a.jpg

相似文献

1
Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.高血压、醛固酮分泌增加及低血浆肾素活性经地塞米松治疗后缓解。
Can Med Assoc J. 1966 Nov 26;95(22):1109-19.
2
Dexamethasone-suppressible hyperaldosteronism.地塞米松可抑制性醛固酮增多症
J Clin Endocrinol Metab. 1973 Jul;37(1):93-100. doi: 10.1210/jcem-37-1-93.
3
Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.家族性、地塞米松可抑制性、正常血钾性醛固酮增多症。
Pediatrics. 1980 Mar;65(3):597-604.
4
Long term evolution of glucocorticoid-suppressible hyperaldosteronism.糖皮质激素可抑制性醛固酮增多症的长期演变
J Clin Endocrinol Metab. 1987 Jan;64(1):22-6. doi: 10.1210/jcem-64-1-22.
5
Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.成人正常血压性糖皮质激素可抑制性醛固酮增多症
Endocrinol Jpn. 1989 Dec;36(6):817-25. doi: 10.1507/endocrj1954.36.817.
6
[Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study].[对肾上腺腺瘤有反应的地塞米松敏感性醛固酮增多症。临床、生物学及遗传学研究]
Presse Med. 1995 Sep 23;24(27):1243-8.
7
An autopsy case of 17 alpha-hydroxylase deficiency with malignant hypertension.一例伴有恶性高血压的17α-羟化酶缺乏症尸检病例。
J Clin Endocrinol Metab. 1983 May;56(5):915-9. doi: 10.1210/jcem-56-5-915.
8
A case of glucocorticoid-responsive hyperaldosteronism.一例糖皮质激素反应性醛固酮增多症。
J Clin Endocrinol Metab. 1968 Dec;28(12):1807-15. doi: 10.1210/jcem-28-12-1807.
9
Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.长期使用地塞米松可纠正糖皮质激素可抑制性醛固酮增多症患者的高血压,并恢复醛固酮对肾素-血管紧张素的反应性。
Clin Exp Pharmacol Physiol. 1985 May-Jun;12(3):245-8. doi: 10.1111/j.1440-1681.1985.tb02640.x.
10
Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).非肿瘤性“原发性”醛固酮增多症。I. 糖皮质激素可缓解型(糖皮质激素可纠正性醛固酮增多症)
Can Med Assoc J. 1969 Jul 12;101(1):1-10.

引用本文的文献

1
Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature.西班牙原发性醛固酮增多症的基因检测:来自西班牙醛固酮增多症(SPAIN-ALDO)注册研究的结果及文献综述
J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1573-e1579. doi: 10.1210/clinem/dgae523.
2
Monogenic Hypertension Linked to the Renin-Angiotensin-Aldosterone System.与肾素-血管紧张素-醛固酮系统相关的单基因高血压
Anatol J Cardiol. 2024 Jun 14;28(9):417-28. doi: 10.14744/AnatolJCardiol.2024.4480.
3
Renal Hypokalemia: An Endocrine Perspective.

本文引用的文献

1
Colorimetric determination of substances containing the grouping -CH(2).CO- in urine extracts as an indication of androgen content.比色法测定尿提取物中含-CH(2).CO-基团的物质以指示雄激素含量。
Biochem J. 1938 Aug;32(8):1312-31. doi: 10.1042/bj0321312.
2
A rapid method for clinical total blood volume determination using radioactive iodinated human serum albumin (RIHSA).一种使用放射性碘化人血清白蛋白(RIHSA)测定临床总血容量的快速方法。
Proc Soc Exp Biol Med. 1951 Jul;77(3):514-8. doi: 10.3181/00379727-77-18832.
3
Observations on the eosinophil count in man; a proposed test of adrenal cortical function.
肾性低钾血症:内分泌学视角
J Clin Endocrinol Metab. 2024 Jun 17;109(7):1694-1706. doi: 10.1210/clinem/dgae201.
4
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism.家族性与散发性原发性醛固酮增多症患者的临床和激素表现差异。
Front Endocrinol (Lausanne). 2024 Mar 1;15:1336306. doi: 10.3389/fendo.2024.1336306. eCollection 2024.
5
Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges.醛固酮受体拮抗剂预防慢性肾脏病进展:当前的证据和未来的挑战。
Int J Mol Sci. 2023 Apr 23;24(9):7719. doi: 10.3390/ijms24097719.
6
18-Oxocortisol: A journey.18-氧皮质醇:一段历程。
J Steroid Biochem Mol Biol. 2023 Jun;230:106291. doi: 10.1016/j.jsbmb.2023.106291. Epub 2023 Mar 13.
7
A narrative review of Hyporeninemic hypertension-an indicator for monogenic forms of hypertension.低肾素性高血压——单基因形式高血压的一个指标的叙述性综述。
Pediatr Med. 2022 May;5. doi: 10.21037/pm-21-48. Epub 2022 May 28.
8
History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology.肾上腺研究史:从古代解剖学到当代分子生物学。
Endocr Rev. 2023 Jan 12;44(1):70-116. doi: 10.1210/endrev/bnac019.
9
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.原发性醛固酮增多症和醛固酮瘤的遗传学研究进展。
Curr Cardiol Rep. 2022 Sep;24(9):1189-1195. doi: 10.1007/s11886-022-01735-z. Epub 2022 Jul 16.
10
Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.原发性醛固酮增多症的发病机制:对临床结局的影响。
Front Endocrinol (Lausanne). 2022 Jun 23;13:927669. doi: 10.3389/fendo.2022.927669. eCollection 2022.
人体嗜酸性粒细胞计数的观察;一种肾上腺皮质功能的拟议检测方法。
Am J Med Sci. 1951 Feb;221(2):121-32. doi: 10.1097/00000441-195102000-00001.
4
Aldosterone secretion and primary and malignant hypertension.醛固酮分泌与原发性和恶性高血压
J Clin Invest. 1960 Jul;39(7):1091-106. doi: 10.1172/JCI104124.
5
[A method for the clinical routine determination of urinary estrogens].[一种临床常规测定尿雌激素的方法]
Zentralbl Gynakol. 1960 Mar 12;82:429-38.
6
ALDOSTERONE SECRETION RATE IN CONGENITAL ADRENAL HYPERPLASIA. A DISCUSSION OF THE THEORIES ON THE PATHOGENESIS OF THE SALT-LOSING FORM OF THE SYNDROME.先天性肾上腺皮质增生症中的醛固酮分泌率。关于该综合征失盐型发病机制理论的讨论。
J Clin Invest. 1965 Sep;44(9):1505-13. doi: 10.1172/JCI105257.
7
SIMULTANEOUS MEASUREMENT OF SECRETORY RATES OF ALDOSTERONE AND 18-HYDROXYCORTICOSTERONE.醛固酮与18-羟皮质酮分泌率的同步测定
J Clin Endocrinol Metab. 1965 Aug;25:1015-26. doi: 10.1210/jcem-25-8-1015.
8
NORMAL AND ALTERED FUNCTION OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN MAN: APPLICATIONS IN CLINICAL AND RESEARCH MEDICINE.人肾素-血管紧张素-醛固酮系统的正常与异常功能:在临床和研究医学中的应用
Ann Intern Med. 1965 Aug;63:266-84. doi: 10.7326/0003-4819-63-2-266.
9
HYPERTENSION AND HYPERALDOSTERONISM OF RENAL AND ADRENAL ORIGIN.肾源性和肾上腺源性高血压与醛固酮增多症
Am J Med. 1965 Mar;38:324-36. doi: 10.1016/0002-9343(65)90142-7.
10
THE EFFECT OF ANGIOTENSIN II ON THE BLOOD PRESSURE IN HUMANS WITH HYPERTENSIVE DISEASE.血管紧张素II对高血压患者血压的影响。
J Clin Invest. 1964 Apr;43(4):659-69. doi: 10.1172/JCI104951.